285 related articles for article (PubMed ID: 18362230)
41. Sorcin ablation plus β-adrenergic stimulation generate an arrhythmogenic substrate in mouse ventricular myocytes.
Chen X; Weber C; Farrell ET; Alvarado FJ; Zhao YT; Gómez AM; Valdivia HH
J Mol Cell Cardiol; 2018 Jan; 114():199-210. PubMed ID: 29174767
[TBL] [Abstract][Full Text] [Related]
42. Arrhythmogenic effects of beta2-adrenergic stimulation in the failing heart are attributable to enhanced sarcoplasmic reticulum Ca load.
Desantiago J; Ai X; Islam M; Acuna G; Ziolo MT; Bers DM; Pogwizd SM
Circ Res; 2008 Jun; 102(11):1389-97. PubMed ID: 18467626
[TBL] [Abstract][Full Text] [Related]
43. β-adrenergic effects on cardiac myofilaments and contraction in an integrated rabbit ventricular myocyte model.
Negroni JA; Morotti S; Lascano EC; Gomes AV; Grandi E; Puglisi JL; Bers DM
J Mol Cell Cardiol; 2015 Apr; 81():162-75. PubMed ID: 25724724
[TBL] [Abstract][Full Text] [Related]
44. Na(+)/K)+)-ATPase α2-isoform preferentially modulates Ca2(+) transients and sarcoplasmic reticulum Ca2(+) release in cardiac myocytes.
Despa S; Lingrel JB; Bers DM
Cardiovasc Res; 2012 Sep; 95(4):480-6. PubMed ID: 22739122
[TBL] [Abstract][Full Text] [Related]
45. Chronic ventricular myocyte-specific overexpression of angiotensin II type 2 receptor results in intrinsic myocyte contractile dysfunction.
Nakayama M; Yan X; Price RL; Borg TK; Ito K; Sanbe A; Robbins J; Lorell BH
Am J Physiol Heart Circ Physiol; 2005 Jan; 288(1):H317-27. PubMed ID: 15374832
[TBL] [Abstract][Full Text] [Related]
46. Maximal acceleration of Ca2+ release refractoriness by β-adrenergic stimulation requires dual activation of kinases PKA and CaMKII in mouse ventricular myocytes.
Poláková E; Illaste A; Niggli E; Sobie EA
J Physiol; 2015 Mar; 593(6):1495-507. PubMed ID: 25772298
[TBL] [Abstract][Full Text] [Related]
47. Serine 68 of phospholemman is critical in modulation of contractility, [Ca2+]i transients, and Na+/Ca2+ exchange in adult rat cardiac myocytes.
Song J; Zhang XQ; Ahlers BA; Carl LL; Wang J; Rothblum LI; Stahl RC; Mounsey JP; Tucker AL; Moorman JR; Cheung JY
Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2342-54. PubMed ID: 15653756
[TBL] [Abstract][Full Text] [Related]
48. Phospholemman phosphorylation alters its fluorescence resonance energy transfer with the Na/K-ATPase pump.
Bossuyt J; Despa S; Martin JL; Bers DM
J Biol Chem; 2006 Oct; 281(43):32765-73. PubMed ID: 16943195
[TBL] [Abstract][Full Text] [Related]
49. Intracellular β
Wang Y; Shi Q; Li M; Zhao M; Reddy Gopireddy R; Teoh JP; Xu B; Zhu C; Ireton KE; Srinivasan S; Chen S; Gasser PJ; Bossuyt J; Hell JW; Bers DM; Xiang YK
Circ Res; 2021 Jan; 128(2):246-261. PubMed ID: 33183171
[TBL] [Abstract][Full Text] [Related]
50. Phospholemman is not required for the acute stimulation of Na⁺-K⁺-ATPase α₂-activity during skeletal muscle fatigue.
Manoharan P; Radzyukevich TL; Hakim Javadi H; Stiner CA; Landero Figueroa JA; Lingrel JB; Heiny JA
Am J Physiol Cell Physiol; 2015 Dec; 309(12):C813-22. PubMed ID: 26468207
[TBL] [Abstract][Full Text] [Related]
51. Phospholemman-dependent regulation of the cardiac Na/K-ATPase activity is modulated by inhibitor-1 sensitive type-1 phosphatase.
El-Armouche A; Wittköpper K; Fuller W; Howie J; Shattock MJ; Pavlovic D
FASEB J; 2011 Dec; 25(12):4467-75. PubMed ID: 21849407
[TBL] [Abstract][Full Text] [Related]
52. Simulation of the effects of moderate stimulation/inhibition of the β1-adrenergic signaling system and its components in mouse ventricular myocytes.
Grinshpon M; Bondarenko VE
Am J Physiol Cell Physiol; 2016 Jun; 310(11):C844-56. PubMed ID: 26936457
[TBL] [Abstract][Full Text] [Related]
53. R4496C RyR2 mutation impairs atrial and ventricular contractility.
Ferrantini C; Coppini R; Scellini B; Ferrara C; Pioner JM; Mazzoni L; Priori S; Cerbai E; Tesi C; Poggesi C
J Gen Physiol; 2016 Jan; 147(1):39-52. PubMed ID: 26666913
[TBL] [Abstract][Full Text] [Related]
54. Na
Karbowski M; Boyman L; Garber L; Joca HC; Verhoeven N; Coleman AK; Ward CW; Lederer WJ; Greiser M
bioRxiv; 2023 Sep; ():. PubMed ID: 37693446
[TBL] [Abstract][Full Text] [Related]
55. Phospholemman overexpression inhibits Na+-K+-ATPase in adult rat cardiac myocytes: relevance to decreased Na+ pump activity in postinfarction myocytes.
Zhang XQ; Moorman JR; Ahlers BA; Carl LL; Lake DE; Song J; Mounsey JP; Tucker AL; Chan YM; Rothblum LI; Stahl RC; Carey DJ; Cheung JY
J Appl Physiol (1985); 2006 Jan; 100(1):212-20. PubMed ID: 16195392
[TBL] [Abstract][Full Text] [Related]
56. Na⁺/K⁺-ATPase E960 and phospholemman F28 are critical for their functional interaction.
Khafaga M; Bossuyt J; Mamikonian L; Li JC; Lee LL; Yarov-Yarovoy V; Despa S; Bers DM
Proc Natl Acad Sci U S A; 2012 Dec; 109(50):20756-61. PubMed ID: 23185013
[TBL] [Abstract][Full Text] [Related]
57. Endothelial nitric oxide synthase decreases beta-adrenergic responsiveness via inhibition of the L-type Ca2+ current.
Wang H; Kohr MJ; Wheeler DG; Ziolo MT
Am J Physiol Heart Circ Physiol; 2008 Mar; 294(3):H1473-80. PubMed ID: 18203845
[TBL] [Abstract][Full Text] [Related]
58. Phospholemman: a novel cardiac stress protein.
Cheung JY; Zhang XQ; Song J; Gao E; Rabinowitz JE; Chan TO; Wang J
Clin Transl Sci; 2010 Aug; 3(4):189-96. PubMed ID: 20718822
[TBL] [Abstract][Full Text] [Related]
59. Tubulin polymerization disrupts cardiac β-adrenergic regulation of late INa.
Dybkova N; Wagner S; Backs J; Hund TJ; Mohler PJ; Sowa T; Nikolaev VO; Maier LS
Cardiovasc Res; 2014 Jul; 103(1):168-77. PubMed ID: 24812278
[TBL] [Abstract][Full Text] [Related]
60. A separate pool of cardiac phospholemman that does not regulate or associate with the sodium pump: multimers of phospholemman in ventricular muscle.
Wypijewski KJ; Howie J; Reilly L; Tulloch LB; Aughton KL; McLatchie LM; Shattock MJ; Calaghan SC; Fuller W
J Biol Chem; 2013 May; 288(19):13808-20. PubMed ID: 23532852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
